-
Evolution of a FLT3-TKD mutated subclone at meningeal relapse in acute promyelocytic leukemia (H021)
Study
EGAS00001001848
-
Next-Generation Sequencing of AV Nodal Reentry Tachycardia patients
Study
EGAS00001002745
-
Dynamics of genome architecture and chromatin function during human B cell differentiation and neoplastic transformation
Study
EGAS00001004763
-
Transcriptional profiling of ovarian tumours and cell lines
Study
EGAS00001004814
-
Colorectal cancer organoids expressing BRAF (fusion) genes
Study
EGAS00001003558
-
MYO5B mutations in Pheochromocytoma/Paraganglioma promote cancer progression
Study
EGAS00001003991
-
Phylogenetic analysis of treatment-naive metastases using whole exome and genome sequencing data
Study
EGAS00001002777
-
A novel breast cancer cell line derived from a metastatic bone lesion of a breast cancer patient
Study
EGAS00001002840
-
Colorectal adenomas, carcinomas and adjacent normal NKI-AvL TGO series NGS-ProToCol
Study
EGAS00001002854
-
Integrated clinical, whole genome, and transcriptome analysis of multisampled lethal metastatic prostate cancer
Study
EGAS00001001659
-
Clonal fitness inferred from timeseries modeling of single cell cancer genomes
Study
EGAS00001004448
-
Versatile workflow for cell-type resolved transcriptional and epigenetic profiles from cryopreserved human lung
Study
EGAS00001004477
-
Identification of Therapeutic Targets in Rhabdomyosarcoma Through Integrated Genomic, Epigenomic, and Proteomic Analyses
Study
EGAS00001002967
-
Detection and characterization of lung cancer using cell-free DNA fragmentomes
Study
EGAS00001005340
-
Human genomic and phenotypic synthetic data for the study of rare diseases
Study
EGAS00001005702
-
Open_Targets_020_Epigenomes_of_Cell_Lines
Study
EGAS00001003137
-
Open_Targets_020_Epigenomes_of_Cell_Lines
Study
EGAS00001003139
-
Healthy_ageing_thymus
Study
EGAS00001004311
-
Novel optineurin frameshift insertion causing familial frontotemporal dementia and parkinsonism without amyotrophic lateral sclerosis
Study
EGAS00001005220
-
Exome-wide mutation analysis of cell-free DNA to simultaneously monitor the full spectrum of cancer treatment outcomes
Study
EGAS00001005906
-
Transcriptome Sequencing PPGL
Study
EGAS00001006044
-
A higher ctDNA fraction decreases survival in regorafenib-treated metastatic colorectal cancer patients
Study
EGAS00001004491
-
Butyrate producers as potential next-generation probiotics: safety assessment of the administration of Butyricicoccus pullicaecorum to healthy volunteers
Study
EGAS00001003276
-
Transcriptomic intra-tumor heterogeneity of colorectal cancer varies depending on tumor location within the colorectum
Study
EGAS00001004668
-
Exome sequencing
Study
EGAS00001005761
-
Mutation-specific non-canonical pathway of PTEN as a distinct therapeutic target for glioblastoma
Study
EGAS00001004753
-
RaScALL: Rapid screening of RNA-seq in acute lymphoblastic leukaemia
Study
EGAS00001006460
-
Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma
Study
EGAS00001003746
-
Colorectal cancer study
Study
EGAS00001006489
-
Robust methylation-based classification of brain tumours using nanopore sequencing
Study
EGAS00001006540
-
Transcriptional_reprogramming_from_innate_immune_functions_to_a_pro_thrombotic_signature_upon_SARS_CoV_2_sensing_by_monocytes_in_COVID_19
Study
EGAS00001006788
-
Non-viral precision T cell receptor replacement for personalized cell therapy
Study
EGAS00001006898
-
Chronic lymphocytic leukemia IGHV somatic hypermutation detection by targeted capture next-generation sequencing
Study
EGAS00001006887
-
PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO-trial
Study
EGAS00001006902
-
Epigenome-wide methylation analysis of colorectal carcinoma, adenoma and normal tissue reveals novel biomarkers addressing unmet clinical needs
Study
EGAS00001007017
-
A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer
Study
EGAS00001007029
-
Treatment stratification and biomarker validation using patient-derived head and neck cancer organoids
Study
EGAS00001007076
-
Whole Exome Sequencing data of six chRCC tumors corresponding to three patients
Study
EGAS00001007104
-
A Machine Learning Tool Integrating Circulating Cell-Free DNA Methylation with Clinical Variables for Non-Invasive Diagnosis of Liver Graft Pathology
Study
EGAS00001007171
-
scRNAseq for patients with immunodeficiency and HCs
Study
EGAS00001007271
-
Analysis of the Elements Involved in the Enrichment of a Panel of Genomic Regions by Nanopore Sequencing Using Adaptive Sampling
Study
EGAS00001007375
-
Efficacy of nivolumab in pediatric cancers with high mutation burden and mismatch-repair deficiency
Study
EGAS00001007393
-
shallow WGS and deep targeted panel on ctDNA in rhabdomyosarcomas
Study
EGAS00001007399
-
Cohesin Mutations in AML
Study
EGAS00001007405
-
Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer
Study
EGAS00001007501
-
Peripheral blood DNA methylome in adalimumab-treated patients with rheumatoid arthritis
Study
EGAS00001007578
-
Evaluation of EBUS-TBNA Aspirates from Advanced NSCLC for Comprehensive Sequencing Platforms Including Whole Genome Sequencing
Study
EGAS00001007708
-
RNA isoform repertoire of neuropsychiatric risk genes in human brain
Study
EGAS00001007744
-
Pharmacogenomic Analysis Reveals New Therapeutic Options for Pleural Mesothelioma
Study
EGAS00001007866
-
The University of Hong Kong Intestinal Metaplasia Organoids Study
Study
EGAS00001007899
-
OMKar
Study
EGAS00001008245
-
Gut metagenome from Estonian Microbiome Cohort
Dataset
EGAD00001008448
-
Clonal selection after gene therapy in sickle cell disease
Dataset
EGAD00001010913
-
KiCS WGS data for academic and for-profit use
Dataset
EGAD00001009699
-
Myeloma Genome Project Targeted Panel Validation dataset
Dataset
EGAD00001008689
-
RNAseq data for Failure of Differentiation of the Rhombic Lip Constitutes Medulloblastoma
Dataset
EGAD00001008458
-
Irish Covid19 WGS Alignment Data
Dataset
EGAD00001010098
-
Case Report: Pre-Clinical Combination Targeting VEGF and PI3K in a Rare, Aggressive Mixed Endometrial Carcinoma
Study
EGAS50000001665
-
Clinical relevance of somatic copy-number alterations in plasma circulating tumor DNA from advanced EGFR-mutated NSCLC patients treated with osimertinib
Study
EGAS00001004539
-
Combination of ribociclib and gemcitabine for the treatment of medulloblastoma
Study
EGAS00001006001
-
Implementation of pediatric precision oncology into clinical practice: The individualized Therapies for Children with cancer program “iTHER”
Study
EGAS00001007099
-
Tremelimumab +/- durvalumab in combination with paclitaxel as immune induction in metastatic urothelial cancer: clinical and translational results of the ICRA trial
Study
EGAS50000001574
-
Whole_genome_sequencing_of_100_DDD_trios_with_suspected_noncoding_causal_mutations
Study
EGAS00001002452
-
A proof-of-concept study of sequential treatment with the HDAC inhibitor vorinostat following BRAF and MEK inhibitors in BRAFV600 mutated melanoma
Study
EGAS00001007709
-
Toxigenic Clostridium perfringens isolated from at-risk pediatric inflammatory bowel disease patients
Study
EGAS50000000334
-
METABRIC
Study
EGAS00000000098
-
Cell-Free DNA Genomic and Fragmentomic Features for Early Outcome Prediction in Diffuse Large B-Cell Lymphoma
Study
EGAS50000000412
-
Phase 1/2 Study of the Indoleamine 2,3-Dioxygenase 1 Inhibitor Linrodostat Mesylate Combined With Nivolumab or Nivolumab and Ipilimumab in Advanced Solid Tumors or Hematologic Malignancies
Study
EGAS50000000710
-
Luminal breast epithelial cells from wildtype and BRCA mutation carriers harbor copy number alterations commonly associated with breast cancer
Study
EGAS00001007716
-
Bone marrow breakout lesions act as key sites for tumor-immune cell diversification and exhaustion in multiple myeloma
Study
EGAS50000000304
-
Discovery and validation of an ancillary genomic test of malignancy for primary melanocytic tumors
Study
EGAS50000000887
-
Cholesterol homeostasis and lipid raft dynamics at the basis of tumor-induced immune dysfunction in chronic lymphocytic leukemia
Study
EGAS50000000933
-
Bladder cancer subtyping study across 4 atezo clinical trials
Study
EGAS50000000497
-
The phase II Neo-Pembro trial: neoadjuvant pembrolizumab in stage IV high-grade serous ovarian cancer
Study
EGAS50000000781
-
Analysis of CD20 loss in patients treated with Mosunetuzumab
Study
EGAS50000000151
-
Repeat expansions with small TTTCA insertions in MARCHF6 cause Familial Adult Myoclonus without Epilepsy
Study
EGAS50000000570
-
Enhancer profiling identifies epigenetic markers of endocrine resistance and reveals therapeutic options for metastatic castration-resistant prostate cancer patients (LuCaP cell line data)
Study
EGAS50000000917
-
Convergent evolution towards CD38 biallelic loss is a recurrent mechanism of resistance to anti-CD38 antibodies in multiple myeloma.
Study
EGAS50000000709
-
IDH-wildtype untreated human glioblastoma samples (GB-UK cohort), published in Noorani & Haughey et al 2025.
Study
EGAS00001008126
-
ATAC-seq: Acquired non-permissive bone marrow microenvironment impairs hematopoietic stem cell proliferation and maintenance and B-cell development post-HSCT
Study
EGAS50000001438
-
Single-cell Transcriptome Profiling of Treatment-naïve and Post-treatment Colorectal Cancer: Insights into Putative Mechanisms of Chemoresistance
Study
EGAS50000000830
-
Development and validation of multivariate predictors of primary endocrine resistance to tamoxifen and aromatase inhibitors in luminal breast cancer reveal drug-specific differences
Study
EGAS50000001102
-
Confronting historical legacies of biological anthropology in South Africa—Restitution, redress and community-centered science: The Sutherland Nine
Study
EGAS50000000971
-
Repotrectinib in NTRK fusion–positive advanced solid tumors: a phase 1/2 trial
Study
EGAS50000001572
-
Recurrent somatic DICER1 mutations in non-epithelial ovarian tumors
Study
EGAS00001000135
-
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Study
EGAS00001000226
-
Accurate mutation detection in leukemia by re-sequencing a cancer gene set
Study
EGAS00001000268
-
Molecular evolution of metastatic clear cell renal cell carcinoma progressing under tyrosine kinase inhibitor therapy (HIPO-045)
Study
EGAS00001001861
-
Influence of age on molecular changes and treatment stratification in multimodal glioblastoma therapy
Study
EGAS00001008246
-
Molecular_diagnosis_of_albinism
Study
EGAS00001002068
-
The light chain IgLV3-21 defines a new poor prognostic subgroup in Chronic Lymphocytic Leukemia: results from a multicenter study
Study
EGAS00001002894
-
Resolving the Full Spectrum of Human Genome Variation using Linked-Reads
Study
EGAS00001003121
-
A genome scan for genes underlying adult body size differences between Central African hunter-gatherers and farmers.
Study
EGAS00001002975
-
Integrated Genomic, Epigenetic, and Expression Analyses of Ovarian Cancer Cell Lines
Study
EGAS00001002998
-
Indonesian Genome Diversity Project
Study
EGAS00001003054
-
Genetic characterization of B-cell prolymphocytic leukemia: a hierarchical prognostic model involving MYC and TP53 abnormalities - WXS
Study
EGAS00001003275
-
Mutational patterns and regulatory networks in epigenetic subgroups of meningioma (H033)
Study
EGAS00001003481
-
An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia (CML)
Study
EGAS00001001751
-
Genomic and epigenomic characterization of juvenile myelomonocytic leukemia (JMML)
Study
EGAS00001002511
-
The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukemia
Study
EGAS00001004212